A Rare Motor Neuron Deleterious Missense Mutation in the DPYSL3 (CRMP4) Gene is Associated with ALS

Human Mutation

Volumn 34, Issue 7, 2013, Pages 953-960

  Blasco, Hélène ^a,b   Bernard Marissal, Nathalie ^c   Vourc'h, Patrick ^a,b   Guettard, Yves Olivier ^a   Sunyach, Claire ^c   Augereau, Olivier ^b   Khederchah, Joelle ^b   Mouzat, Kevin ^d   Antar, Catherine ^a,b   Gordon, Paul H ^e   Veyrat Durebex, Charlotte ^a,b   Besson, Gérard ^f   Andersen, Peter M ^g   Salachas, François ^e   Meininger, Vincent ^e   Camu, William ^h   Pettmann, Brigitte ^c   Andres, Christian R ^a,b   Corcia, Philippe ^a,i   Pautot, V ^j   Nicolas, G ^j   Rumbach, L ^j   Clavelou, P ^j   Guy, N ^j   Besson, G ^j   Destee A ^j   Brunaud Danel, V ^j   Couratier, P ^j   Funalot, B ^j   Broussole, E ^j   Vial, C ^j   Vandenberghe, N ^j   Camu, W ^j   Morales, R ^j   Pageot, N ^j   Debouverie, M ^j   Pittion, S ^j   Desnuelle, C ^j   Soriani, M H ^j   Lemasson, G ^j   Meininger, V ^j   Salachas, F ^j   Pradat, P F ^j   Dib, M ^j   Bruneteau, G ^j   Leforestier, N ^j   Pouget, J ^j   Verschuren, A ^j   Viader, F ^j   Carluer, L ^j   Tranchant, C ^j   Fleury, M C ^j   Antoine, J C ^j   Camdessanche, J P ^j   Arne Bes, M C ^j   Cintas, P ^j   Corcia, P ^j   Praline, J ^j   more..

^a UNIVERSITÉ DE TOURS   (France)

^b CHU BRETONNEAU   (France)

^c Turing Center for Living Systems CENTURI Aix Marseille University   (France)

^d NÎMES UNIVERSITY HOSPITAL   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f GRENOBLE UNIVERSITY HOSPITAL   (France)

^g UMEÅ UNIVERSITY   (Sweden)

^h GUI DE CHAULIAC HOSPITAL   (France)

ⁱ UNIVERSITY HOSPITAL OF TOURS   (France)

^j NONE

more..

Author keywords

ALS; CRMP4; DPYSL3; Risk factor

Indexed keywords

ADULT; AGED; ALSDIHYDROPYRIMIDINASE LIKE 3 GENE; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DEATH; CELL SURVIVAL; COLLAPSIN RESPONSE MEDIATOR PROTEIN 4A GENE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MOTONEURON; MOUSE; NERVE DEGENERATION; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; AXONS; CELL DEATH; CELLS, CULTURED; FEMALE; FRANCE; HUMANS; MALE; MICE; MOTOR NEURONS; MUSCLE PROTEINS; MUTATION, MISSENSE; SWEDEN;

EID: 84879422064     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.22329     Document Type: Article

References (64)

1. Abel O, Powell JF, Andersen PM, Al-Chalabi A. 2012. ALSoD: A user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics. Hum Mutat 33(9):1345-1351.
2. Alabed YZ, Pool M, Ong Tone S, Sutherland C, Fournier AE. 2010. GSK3 beta regulates myelin-dependent axon outgrowth inhibition through CRMP4. J Neurosci 30(16):5635-5643.
3. Andersen PM. 2006. Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene. Curr Neurol Neurosci Rep 6(1):37-46.
4. Andersen PM, Al-Chalabi A. 2011. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol 7(11):603-615.
5. Arce V, Garces A, de Bovis B, Filippi P, Henderson C, Pettmann B, deLapeyriere O. 1999. Cardiotrophin-1 requires LIFRbeta to promote survival of mouse motoneurons purified by a novel technique. J Neurosci Res 55(1):119-126.
6. Auvergnon N, Reibel S, Touret M, Honnorat J, Baron T, Giraudon P, Bencsik A. 2009. Altered expression of CRMPs in the brain of bovine spongiform encephalopathy-infected mice during disease progression. Brain Res 1261:1-6.
7. Beghi E, Logroscino G, Chio A, Hardiman O, Mitchell D, Swingler R, Traynor BJ. 2006. The epidemiology of ALS and the role of population-based registries. Biochim Biophys Acta 1762(11-12):1150-1157.
8. Bernard-Marissal N, Moumen A, Sunyach C, Pellegrino C, Dudley K, Henderson CE, Raoul C, Pettmann B. 2012. Reduced calreticulin levels link endoplasmic reticulum stress and Fas-triggered cell death in motoneurons vulnerable to ALS. J Neurosci 32(14):4901-4912.
9. Blauw HM, Veldink JH, van Es MA, van Vught PW, Saris CG, van der Zwaag B, Franke L, Burbach JP, Wokke JH, Ophoff RA, van den Berg LH. 2008. Copy-number variation in sporadic amyotrophic lateral sclerosis: a genome-wide screen. Lancet Neurol 7(4):319-326.
10. Brooks BR, Miller RG, Swash M, Munsat TL. 2000. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1(5):293-299.
11. Byk T, Dobransky T, Cifuentes-Diaz C, Sobel A. 1996. Identification and molecular characterization of Unc-33-like phosphoprotein (Ulip), a putative mammalian homolog of the axonal guidance-associated unc-33 gene product. J Neurosci 16(2):688-701.
12. Byk T, Ozon S, Sobel A. 1998. The Ulip family phosphoproteins-common and specific properties. Eur J Biochem 254(1):14-24.
13. Cashman NR, Durham HD, Blusztajn JK, Oda K, Tabira T, Shaw IT, Dahrouge S, Antel JP. 1992. Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dyn 194(3):209-221.
14. Charrier E, Reibel S, Rogemond V, Aguera M, Thomasset N, Honnorat J. 2003. Collapsin response mediator proteins (CRMPs): involvement in nervous system development and adult neurodegenerative disorders. Mol Neurobiol 28(1):51-64.
15. Chio A, Calvo A, Moglia C, Mazzini L, Mora G. 2011. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 82(7):740-746.
16. Cole AR, Soutar MP, Rembutsu M, van Aalten L, Hastie CJ, McLauchlan H, Peggie M, Balastik M, Lu KP, Sutherland C. 2008. Relative resistance of Cdk5-phosphorylated CRMP2 to dephosphorylation. J Biol Chem 283(26):18227-18237.
17. Cronin S, Berger S, Ding J, Schymick JC, Washecka N, Hernandez DG, Greenway MJ, Bradley DG, Traynor BJ, Hardiman O. 2008. A genome-wide association study of sporadic ALS in a homogenous Irish population. Hum Mol Genet 17(5):768-774.
18. Cronin S, Tomik B, Bradley DG, Slowik A, Hardiman O. 2009. Screening for replication of genome-wide SNP associations in sporadic ALS. Eur J Hum Genet 17(2):213-218.
19. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, Kouri N, Wojtas A, et al. 2011. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72(2):245-256.
20. Dunckley T, Huentelman MJ, Craig DW, Pearson JV, Szelinger S, Joshipura K, Halperin RF, Stamper C, Jensen KR, Letizia D, Hesterlee SE, Pestronk A, et al. 2007. Whole-genome analysis of sporadic amyotrophic lateral sclerosis. N Engl J Med 357(8):775-788.
21. Duplan L, Bernard N, Casseron W, Dudley K, Thouvenot E, Honnorat J, Rogemond V, De Bovis B, Aebischer P, Marin P, Raoul C, Henderson CE, et al. 2010. Collapsin response mediator protein 4a (CRMP4a) is upregulated in motoneurons of mutant SOD1 mice and can trigger motoneuron axonal degeneration and cell death. J Neurosci 30(2):785-796.
22. Gaetano C, Matsuo T, Thiele CJ. 1997. Identification and characterization of a retinoic acid-regulated human homologue of the unc-33-like phosphoprotein gene (hUlip) from neuroblastoma cells. J Biol Chem 272(18):12195-12201.
23. Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, Levitch D, Hatanpaa KJ, White CL, 3rd, Bigio EH, Caselli R, Baker M, Al-Lozi MT, et al. 2008. TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol 63(4):535-538.
24. Goshima Y, Nakamura F, Strittmatter P, Strittmatter SM. 1995. Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature 376(6540):509-514.
25. 2 toxicity. J Neurochem 95(2):466-474.
26. Kwiatkowski TJ, Jr., Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis EJ, Munsat T, Valdmanis P, Rouleau GA, et al. 2009. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323(5918):1205-1208.
27. Laaksovirta H, Peuralinna T, Schymick JC, Scholz SW, Lai SL, Myllykangas L, Sulkava R, Jansson L, Hernandez DG, Gibbs JR, Nalls MA, Heckerman D, et al. 2010. Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study. Lancet Neurol 9(10):978-985.
28. Landers JE, Melki J, Meininger V, Glass JD, van den Berg LH, van Es MA, Sapp PC, van Vught PW, McKenna-Yasek DM, Blauw HM, Cho TJ, Polak M, et al. 2009. Reduced expression of the Kinesin-associated protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 106(22):9004-9009.
29. Lattante S, Conte A, Zollino M, Luigetti M, Del Grande A, Marangi G, Romano A, Marcaccio A, Meleo E, Bisogni G, Rossini PM, Sabatelli M. 2012. Contribution of major amyotrophic lateral sclerosis genes to the etiology of sporadic disease. Neurology 79(1):66-72.
30. Liu PC, Yang ZJ, Qiu MH, Zhang LM, Sun FY. 2003. Induction of CRMP-4 in striatum of adult rat after transient brain ischemia. Acta Pharmacol Sin 24(12):1205-1211.
31. Majounie E, Renton AE, Mok K, Dopper EG, Waite A, Rollinson S, Chio A, Restagno G, Nicolaou N, Simon-Sanchez J, van Swieten JC, Abramzon Y, et al. 2012. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol 11(4):323-330.
32. Millecamps S, Boillee S, Le Ber I, Seilhean D, Teyssou E, Giraudeau M, Moigneu C, Vandenberghe N, Danel-Brunaud V, Corcia P, Pradat PF, Le Forestier N, et al. 2012. Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes. J Med Genet 49(4):258-263.
33. Minturn JE, Fryer HJ, Geschwind DH, Hockfield S. 1995. TOAD-64, a gene expressed early in neuronal differentiation in the rat, is related to unc-33, a C. elegans gene involved in axon outgrowth. J Neurosci 15(10):6757-7566.
34. Nacher J, Rosell DR, McEwen BS. 2000. Widespread expression of rat collapsin response-mediated protein 4 in the telencephalon and other areas of the adult rat central nervous system. J Comp Neurol 424(4):628-639.
35. Orsetti V, Pegoraro E, Cima V, D'Ascenzo C, Palmieri A, Querin G, Volpe M, Ermani M, Angelini C, Soraru G. 2011. Genetic variation in KIFAP3 is associated with an upper motor neuron-predominant phenotype in amyotrophic lateral sclerosis. Neurodegener Dis 8(6):491-495.
36. Pasterkamp RJ, Verhaagen J. 2001. Emerging roles for semaphorins in neural regeneration. Brain Res Brain Res Rev 35(1):36-54.
37. Quinn CC, Chen E, Kinjo TG, Kelly G, Bell AW, Elliott RC, McPherson PS, Hockfield S. 2003. TUC-4b, a novel TUC family variant, regulates neurite outgrowth and associates with vesicles in the growth cone. J Neurosci 23(7):2815-2823.
38. Quinn CC, Gray GE, Hockfield S. 1999. A family of proteins implicated in axon guidance and outgrowth. J Neurobiol 41(1):158-164.
39. Raoul C, Abbas-Terki T, Bensadoun JC, Guillot S, Haase G, Szulc J, Henderson CE, Aebischer P. 2005. Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS. Nat Med 11(4):423-428.
40. Raoul C, Estevez AG, Nishimune H, Cleveland DW, deLapeyriere O, Henderson CE, Haase G, Pettmann B. 2002. Motoneuron death triggered by a specific pathway downstream of Fas. potentiation by ALS-linked SOD1 mutations. Neuron 35(6):1067-1083.
41. Ratti A, Corrado L, Castellotti B, Del Bo R, Fogh I, Cereda C, Tiloca C, D'Ascenzo C, Bagarotti A, Pensato V, Ranieri M, Gagliardi S, et al. 2012. C9ORF72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect. Neurobiol Aging 33(10):2528 e7-14.
42. Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, Kalimo H, Paetau A, et al. 2011. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72(2):257-268.
43. Rosen DR. 1993. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 364(6435):362.
44. Rosslenbroich V, Dai L, Baader SL, Noegel AA, Gieselmann V, Kappler J. 2005. Collapsin response mediator protein-4 regulates F-actin bundling. Exp Cell Res 310(2):434-444.
45. Schmidt EF, Strittmatter SM. 2007. The CRMP family of proteins and their role in Sema3A signaling. Adv Exp Med Biol 600:1-11.
46. Schymick JC, Scholz SW, Fung HC, Britton A, Arepalli S, Gibbs JR, Lombardo F, Matarin M, Kasperaviciute D, Hernandez DG, Crews C, Bruijn L, et al. 2007. Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol 6(4):322-328.
47. Sha Q, Zhang Z, Schymick JC, Traynor BJ, Zhang S. 2009. Genome-wide association reveals three SNPs associated with sporadic amyotrophic lateral sclerosis through a two-locus analysis. BMC Med Genet 10(1):86.
48. Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, Ackerley S, Durnall JC, Williams KL, Buratti E, Baralle F, de Belleroche J, et al. 2008. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319(5870):1668-1672.
49. Sunyaev S, Ramensky V, Koch I, Lathe W, 3rd, Kondrashov AS, Bork P. 2001. Prediction of deleterious human alleles. Hum Mol Genet 10(6):591-597.
50. Suzuki Y, Nakagomi S, Namikawa K, Kiryu-Seo S, Inagaki N, Kaibuchi K, Aizawa H, Kikuchi K, Kiyama H. 2003. Collapsin response mediator protein-2 accelerates axon regeneration of nerve-injured motor neurons of rat. J Neurochem 86(4):1042-1050.
51. Towne C, Raoul C, Schneider BL, Aebischer P. 2008. Systemic AAV6 delivery mediating RNA interference against SOD1: neuromuscular transduction does not alter disease progression in fALS mice. Mol Ther 16(6):1018-1025.
52. Uchida Y, Ohshima T, Sasaki Y, Suzuki H, Yanai S, Yamashita N, Nakamura F, Takei K, Ihara Y, Mikoshiba K, Kolattukudy P, Honnorat J, et al. 2005. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease. Genes Cells 10(2):165-179.
53. Valdez G, Tapia JC, Lichtman JW, Fox MA, Sanes JR. 2012. Shared resistance to aging and ALS in neuromuscular junctions of specific muscles. PLoS ONE 7(4):e34640.
54. van Blitterswijk M, van Es MA, Hennekam EA, Dooijes D, van Rheenen W, Medic J, Bourque PR, Schelhaas HJ, van der Kooi AJ, de Visser M, de Bakker PI, Veldink JH, et al. 2012. Evidence for an oligogenic basis of amyotrophic lateral sclerosis. Hum Mol Genet 21:3776-3784.
55. van Es MA, Van Vught PW, Blauw HM, Franke L, Saris CG, Andersen PM, Van Den Bosch L, de Jong SW, van 't Slot R, Birve A, Lemmens R, de Jong V, et al. 2007. ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study. Lancet Neurol 6(10):869-877.
56. van Es MA, Veldink JH, Saris CG, Blauw HM, van Vught PW, Birve A, Lemmens R, Schelhaas HJ, Groen EJ, Huisman MH, van der Kooi AJ, de Visser M, et al. 2009. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat Genet 41:1083-1087.
57. Van Hoecke A, Schoonaert L, Lemmens R, Timmers M, Staats KA, Laird AS, Peeters E, Philips T, Goris A, Dubois B, Andersen PM, Al-Chalabi A, et al. 2012. EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans. Nat Med 18:1418-1422.
58. van Rheenen W, van Blitterswijk M, Huisman MH, Vlam L, van Doormaal PT, Seelen M, Medic J, Dooijes D, de Visser M, van der Kooi AJ, Raaphorst J, Schelhaas HJ, et al. 2012. Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases. Neurology 79(9):878-882.
59. Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, Sreedharan J, Hu X, Smith B, Ruddy D, Wright P, Ganesalingam J, Williams KL, et al. 2009. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323(5918):1208-1211.
60. Wang LH, Strittmatter SM. 1996. A family of rat CRMP genes is differentially expressed in the nervous system. J Neurosci 16(19):6197-6207.
61. Wang LH, Strittmatter SM. 1997. Brain CRMP forms heterotetramers similar to liver dihydropyrimidinase. J Neurochem 69(6):2261-2269.
62. Yoshida H, Watanabe A, Ihara Y. 1998. Collapsin response mediator protein-2 is associated with neurofibrillary tangles in Alzheimer's disease. J Biol Chem 273(16):9761-9768.
63. Yoshida M, Takahashi Y, Koike A, Fukuda Y, Goto J, Tsuji S. 2010. A mutation database for amyotrophic lateral sclerosis. Hum Mutat 31(9):1003-1010.
64. Yoshimura T, Arimura N, Kaibuchi K. 2006. Molecular mechanisms of axon specification and neuronal disorders. Ann N Y Acad Sci 1086:116-125.